Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

ConditionsAtrial Fibrillation Coronary Artery Disease Anticoagulants

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorZuyderland Medisch Centrum

About this trial

A prospective, multicenter, 1:1 randomized, investigator initiated study. Goal of this study is to examine the safety of uninterrupted periprocedural DOAC use.

Eligibility criteria

Qualifiers

Patients aged >18 years using DOAC and undergoing elective ICA or PCI.

Provided signed informed consent

Disqualifiers

Patients initially presenting with Acute Coronary Syndrome (STEMI, NSTEMI, UA)

Patients <18 years old

Calculated creatinine clearance <30 mL/min

Patients simultaneously participating in another clinical trial

Trial design

Treatments tested in this trial

Uninterrupted DOAC use
Interrupted DOAC use

Treatment groups

1,270 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Zuyderland Medisch Centrum

Lead sponsor

Source ClinicalTrials.gov